These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 30653520)
1. Differential modulation and prognostic values of immune-escape genes in uveal melanoma. Basile MS; Mazzon E; Russo A; Mammana S; Longo A; Bonfiglio V; Fallico M; Caltabiano R; Fagone P; Nicoletti F; Avitabile T; Reibaldi M PLoS One; 2019; 14(1):e0210276. PubMed ID: 30653520 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the Pathophysiological Role of CD47 in Uveal Melanoma. Petralia MC; Mazzon E; Fagone P; Russo A; Longo A; Avitabile T; Nicoletti F; Reibaldi M; Basile MS Molecules; 2019 Jul; 24(13):. PubMed ID: 31277366 [TBL] [Abstract][Full Text] [Related]
3. The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma. Wang Y; Xu Y; Dai X; Lin X; Shan Y; Ye J Exp Eye Res; 2020 Jul; 196():108069. PubMed ID: 32439398 [TBL] [Abstract][Full Text] [Related]
4. Role of immune checkpoint inhibitors and novel immunotherapies in uveal melanoma. Jindal V Chin Clin Oncol; 2018 Feb; 7(1):8. PubMed ID: 29486567 [TBL] [Abstract][Full Text] [Related]
5. The Role of Immune Checkpoint Blockade in Uveal Melanoma. Wessely A; Steeb T; Erdmann M; Heinzerling L; Vera J; Schlaak M; Berking C; Heppt MV Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013269 [TBL] [Abstract][Full Text] [Related]
6. Additive Role of Immune System Infiltration and Angiogenesis in Uveal Melanoma Progression. García-Mulero S; Alonso MH; Del Carpio LP; Sanz-Pamplona R; Piulats JM Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800878 [TBL] [Abstract][Full Text] [Related]
7. Meng Z; Chen Y; Wu W; Yan B; Zhang L; Chen H; Meng Y; Liang Y; Yao X; Luo J Front Immunol; 2022; 13():754645. PubMed ID: 35281030 [TBL] [Abstract][Full Text] [Related]
9. CD166high Uveal Melanoma Cells Represent a Subpopulation With Enhanced Migratory Capacity. Djirackor L; Kalirai H; Coupland SE; Petrovski G Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2696-2704. PubMed ID: 31242292 [TBL] [Abstract][Full Text] [Related]
10. Mass Spectrometry-Based Profiling of Histone Post-Translational Modifications in Uveal Melanoma Tissues, Human Melanocytes, and Uveal Melanoma Cell Lines - A Pilot Study. Herwig-Carl MC; Sharma A; Tischler V; Pelusi N; Loeffler KU; Holz FG; Zeschnigk M; Landreville S; Auw-Haedrich C; Noberini R; Bonaldi T Invest Ophthalmol Vis Sci; 2024 Feb; 65(2):27. PubMed ID: 38349785 [TBL] [Abstract][Full Text] [Related]
11. The immune cell landscape of metastatic uveal melanoma correlates with overall survival. Tosi A; Cappellesso R; Dei Tos AP; Rossi V; Aliberti C; Pigozzo J; Fabozzi A; Sbaraglia M; Blandamura S; Del Bianco P; Chiarion-Sileni V; Rosato A J Exp Clin Cancer Res; 2021 May; 40(1):154. PubMed ID: 33947438 [TBL] [Abstract][Full Text] [Related]
12. In-depth proteomic profiling of the uveal melanoma secretome. Angi M; Kalirai H; Prendergast S; Simpson D; Hammond DE; Madigan MC; Beynon RJ; Coupland SE Oncotarget; 2016 Aug; 7(31):49623-49635. PubMed ID: 27391064 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of deregulated microRNAs in uveal melanomas. Falzone L; Romano GL; Salemi R; Bucolo C; Tomasello B; Lupo G; Anfuso CD; Spandidos DA; Libra M; Candido S Mol Med Rep; 2019 Apr; 19(4):2599-2610. PubMed ID: 30816460 [TBL] [Abstract][Full Text] [Related]
14. Butyrophilin-Like 9 (BTNL9) Suppresses Invasion and Correlates with Favorable Prognosis of Uveal Melanoma. Jiang Z; Liu F Med Sci Monit; 2019 Apr; 25():3190-3198. PubMed ID: 31039142 [TBL] [Abstract][Full Text] [Related]
15. Digital PCR-Based T-cell Quantification-Assisted Deconvolution of the Microenvironment Reveals that Activated Macrophages Drive Tumor Inflammation in Uveal Melanoma. de Lange MJ; Nell RJ; Lalai RN; Versluis M; Jordanova ES; Luyten GPM; Jager MJ; van der Burg SH; Zoutman WH; van Hall T; van der Velden PA Mol Cancer Res; 2018 Dec; 16(12):1902-1911. PubMed ID: 30093564 [TBL] [Abstract][Full Text] [Related]
16. Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanoma. de Lange MJ; van Pelt SI; Versluis M; Jordanova ES; Kroes WG; Ruivenkamp C; van der Burg SH; Luyten GP; van Hall T; Jager MJ; van der Velden PA Oncotarget; 2015 Nov; 6(35):37824-35. PubMed ID: 26462151 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological relevance of NFκB1/p50 nuclear immunoreactivity and its relationship with the inflammatory environment of uveal melanoma. Singh MK; Singh L; Chosdol K; Pushker N; Meel R; Bakhshi S; Sen S; Kashyap S Exp Mol Pathol; 2019 Dec; 111():104313. PubMed ID: 31533021 [TBL] [Abstract][Full Text] [Related]
18. Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy. Qin Y; Bollin K; de Macedo MP; Carapeto F; Kim KB; Roszik J; Wani KM; Reuben A; Reddy ST; Williams MD; Tetzlaff MT; Wang WL; Gombos DS; Esmaeli B; Lazar AJ; Hwu P; Patel SP J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33203661 [TBL] [Abstract][Full Text] [Related]
19. A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of alpha1beta1, alpha4beta1 and alpha6beta1 integrins. Elshaw SR; Sisley K; Cross N; Murray AK; MacNeil SM; Wagner M; Nichols CE; Rennie IG Br J Ophthalmol; 2001 Jun; 85(6):732-8. PubMed ID: 11371496 [TBL] [Abstract][Full Text] [Related]
20. Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets. Basile MS; Mazzon E; Fagone P; Longo A; Russo A; Fallico M; Bonfiglio V; Nicoletti F; Avitabile T; Reibaldi M Front Oncol; 2019; 9():1145. PubMed ID: 31750244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]